ATE357229T1 - Ibuprofenhaltige weichgelatinekapseln - Google Patents

Ibuprofenhaltige weichgelatinekapseln

Info

Publication number
ATE357229T1
ATE357229T1 AT00959667T AT00959667T ATE357229T1 AT E357229 T1 ATE357229 T1 AT E357229T1 AT 00959667 T AT00959667 T AT 00959667T AT 00959667 T AT00959667 T AT 00959667T AT E357229 T1 ATE357229 T1 AT E357229T1
Authority
AT
Austria
Prior art keywords
ibuprofen
gelatin capsules
soft gelatin
capsules containing
containing ibuprofen
Prior art date
Application number
AT00959667T
Other languages
German (de)
English (en)
Inventor
Rampurna Prasad Gullapalli
Original Assignee
Banner Pharmacaps Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23536433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE357229(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Banner Pharmacaps Inc filed Critical Banner Pharmacaps Inc
Application granted granted Critical
Publication of ATE357229T1 publication Critical patent/ATE357229T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00959667T 1999-09-02 2000-09-01 Ibuprofenhaltige weichgelatinekapseln ATE357229T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/389,003 US6251426B1 (en) 1999-09-02 1999-09-02 Ibuprofen-containing softgels

Publications (1)

Publication Number Publication Date
ATE357229T1 true ATE357229T1 (de) 2007-04-15

Family

ID=23536433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00959667T ATE357229T1 (de) 1999-09-02 2000-09-01 Ibuprofenhaltige weichgelatinekapseln

Country Status (9)

Country Link
US (1) US6251426B1 (enExample)
EP (1) EP1207872B1 (enExample)
JP (1) JP2003508434A (enExample)
AT (1) ATE357229T1 (enExample)
AU (1) AU780212B2 (enExample)
CA (1) CA2382292C (enExample)
DE (1) DE60034044T2 (enExample)
PL (1) PL362850A1 (enExample)
WO (1) WO2001015688A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020177626A1 (en) * 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
US6551615B1 (en) * 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
ES2302926T5 (es) * 2002-04-25 2012-08-23 Banner Pharmacaps, Inc. Cápsula blanda masticable
US20030232097A1 (en) * 2002-06-17 2003-12-18 Strides Inc. Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
CA2498207C (en) * 2002-09-11 2012-03-13 Elan Pharma International Ltd. Gel-stabilized nanoparticulate active agent compositions
KR20040106915A (ko) * 2003-06-05 2004-12-20 한국유나이티드제약 주식회사 가용성 이부프로펜의 연질캅셀제 조성물 및 그의 제조방법
USD530814S1 (en) 2003-09-16 2006-10-24 Novartis Ag Combined capsule and tablets
USD520635S1 (en) 2003-09-16 2006-05-09 Novartis Ag Combine capsule and tablets
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
CA2554243A1 (en) * 2004-01-20 2005-08-11 Stiefel Laboratories, Inc. Dermatologic soft gel compositions
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
CA2570649A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
US20070053868A1 (en) 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
US20060240051A1 (en) * 2005-04-26 2006-10-26 Singleton Andy H Eutectic blends containing a water soluble vitamin derivative
JP5406529B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
US8497303B2 (en) * 2008-01-18 2013-07-30 Dow Global Technologies Llc Method to enhance aqueous solubility of poorly soluble actives
US20090214648A1 (en) * 2008-02-15 2009-08-27 Malathi Kandakatla Pharmaceutical formulations comprising ibuprofen and diphenhydramine
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
DE102010063609A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure
MX364440B (es) * 2013-03-15 2019-04-26 Warner Chilcott Co Llc Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada.
JP6451310B2 (ja) 2014-12-24 2019-01-16 ライオン株式会社 固形医薬組成物及びその製造方法
EP3053598A1 (en) 2015-02-06 2016-08-10 Faes Farma, S.A. Calcifediol soft capsules
GB2595301B (en) * 2020-05-21 2025-01-08 Reckitt Benckiser Health Ltd Novel Formulation
WO2025150072A1 (en) * 2024-01-13 2025-07-17 Pulse Pharmaceuticals Pvt Ltd A stable oral pro-dispersion formulation and implementations thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
DE3437599C2 (de) * 1984-10-13 1987-04-16 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende Weichgelatinekapseln
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US4900775A (en) 1988-02-29 1990-02-13 Gaf Chemicals Corporation Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
US5376688A (en) 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5431916A (en) 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
JPH08509725A (ja) 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
CA2181241C (en) 1994-01-24 2000-04-25 Dadi Jamshed Dhabhar Process for solubilizing difficultly soluble pharmaceutical actives
US5484606A (en) 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
US5538737A (en) 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5468502A (en) 1994-12-20 1995-11-21 American Home Products Corporation Ibuprofen enhancing solvent system
US5660859A (en) 1994-12-29 1997-08-26 Mcneil-Ppc, Inc. Gelling agent for polyethylene glycol
US5641512A (en) 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
EP0839029A1 (en) * 1995-07-20 1998-05-06 PHARMACIA & UPJOHN COMPANY Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
US6221391B1 (en) 1998-11-23 2001-04-24 Accucaps Industries Limited Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith

Also Published As

Publication number Publication date
AU780212B2 (en) 2005-03-10
AU7094900A (en) 2001-03-26
WO2001015688A1 (en) 2001-03-08
PL362850A1 (pl) 2004-11-02
DE60034044D1 (de) 2007-05-03
CA2382292C (en) 2008-02-26
EP1207872B1 (en) 2007-03-21
US6251426B1 (en) 2001-06-26
JP2003508434A (ja) 2003-03-04
CA2382292A1 (en) 2001-03-08
EP1207872A1 (en) 2002-05-29
DE60034044T2 (de) 2007-12-06

Similar Documents

Publication Publication Date Title
ATE357229T1 (de) Ibuprofenhaltige weichgelatinekapseln
JP3739391B2 (ja) 強化溶解度の製薬溶液
ATE407666T1 (de) Kaubare weichkapseln mit verbesserten verabreichungseigenschaften sowie verfahren zu deren herstellung
FR2737121B1 (fr) Nouvelles formulations galeniques du fenofibrate et leurs applications
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
IT1281337B1 (it) Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
NO20016107L (no) Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
WO2003068144A3 (en) Cytotoxic agents
EE03425B1 (et) Lihtsa koostise ja kõrge biosaadavusega tsüklosporiini preparaadid suu kaudu manustamiseks ja nende valmistamismeetod
CO4940403A1 (es) Formulaciones de liberacion prolongada de derivados de eri- tromicina
CA2397447A1 (en) Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications
DK1611892T3 (da) Farmaceutiske sammensætninger indeholdende drospirenon
DK1189620T3 (da) Formulering indeholdende testosteronundecanoat og amerikansk olie
DK1237423T3 (da) Stabil, spraytörret sammensætning i et carbonhydratsubstrat samt fremgangsmåde til opnåelse af sammensætningen
CA2366679A1 (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
ATE252376T1 (de) Retinolhaltiges arzneimittel kompatibel mit weichgelatinekapseln
KR900004322A (ko) 에토포시드 용액
CA2296016A1 (en) Polyoxyalkylene glycol gelatin capsule fill formulations comprising crosslinked carboxylic copolymers
BG104527A (en) Formulations comprising dissolved paroxetine
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
JPS5750914A (en) Betamethasone external pharmaceutical
JP2003526680A5 (enExample)
MXPA05008921A (es) Formulaciones orales semisolidas para liberacion inmediata que comprenden un agente hidrofobo anticancer, un glicerido poliglicolisado y un vehiculo hidrofilo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties